Aromatase inhibitors ‘eclipse tamoxifen’ in younger women
Among patients with early breast cancer undergoing ovarian suppression, aromatase inhibitors cut tumour recurrence by a third, data show.
Tag: Breast cancer
Fat cell changes ‘may promote breast cancer metastases’ in T2DM
Insulin resistance triggers exosomes to deliver more cancer-linked proteins to the malignant cells, research shows.
Low representation in clinical trials ‘tied to real-world harms’
The issue translates into poorer survival for some women with early breast cancer, researchers say.
It’s shocking not all breast cancer patients are told about reconstruction
This article marks Breast Reconstruction Awareness Day on 20 October 2021. A few weeks ago, I was sitting in a hospital bed recovering from major surgery. I had four tubes and…
Clinical breast exams ‘low value’ for women with genetic risk
A retrospective study of Australian patients under intense surveillance because of germline mutations shows the exams don’t improve cancer detect…
BRCA variants linked to increased cancer survival: study
Patients with inherited genetic mutations may be more responsive to chemotherapy, researchers say.
Breast microcalcifications tied to cardiometabolic risk: study
But more research is needed on how to utilise the information from screening without alarming patients, authors say.
Shorter spell of endocrine therapy ‘sufficient’ for breast cancer
Results are strong evidence against routine extended use in women with hormone-receptor positive disease, expert says.
Real-world survival ‘inferior’ to trials for ERBB2-positive metastatic cancer
Canadian data differs from results seen in the CLEOPATRA and EMILIA trials, researchers report.
Long-term bisphosphonate in breast cancer ‘provides no extra benefit’
It may be time to question the role of the bone-sparing therapy, say expert commentators.
